Position in EPRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$9,717,368
+$6,687 QoQ
Shares Held
1,342,178
+4.4% QoQ
Ownership
2.05%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#5
of 54 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SCOTIA CAPITAL INC. holds $18,289,216 across 14 Biotechnology names. EPRX ranks #1 (53.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EPRX |
Eupraxia Pharmaceuticals Inc.
This page
|
1,342,178 | $9,717,368 | |
| 2 | BNTX |
BioNTech SE
|
45,000 | $3,999,600 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,861 | $2,170,630 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
40,548 | $766,357 | |
| 5 | EYPT |
EyePoint, Inc.
|
41,751 | $538,170 | |
| 6 | LXRX |
Lexicon Pharmaceuticals, Inc.
|
159,831 | $249,336 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
1,164 | $232,392 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
7,048 | $229,341 |
All Filings in EPRX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,717,368 | 1,342,178 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $9,710,681 | 1,286,183 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $7,539,521 | 1,277,885 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,441,856 | 1,291,989 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $5,092,787 | 1,552,679 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $4,411,749 | 1,391,719 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,672,219 | 1,396,281 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,526,991 | 1,367,051 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||